Capital Health

capital-health.ae

Capital Health, headquartered in Abu Dhabi, is a private integrated healthcare group that operates two healthcare facilities in the UAE: Specialized Rehabilitation Hospital (SRH) - a specialty hospital that provides acute and long-term rehabilitation care, along with inpatient, outpatient and Home Health capabilities; and Health Shield Medical Center - a multi-specialty healthcare facility with outpatient (one-day surgery) capabilities.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

INDUSTRIAL IMPACT

LYGOS AND FLEXIBLE SOLUTIONS INTERNATIONAL ANNOUNCE REGISTRATION STATEMENT ON FORM S-4 RELATED TO PROPOSED MERGER

Lygos Inc | July 26, 2022

news image

Lygos Inc., a vertically integrated biotechnology provider of sustainable specialty ingredients, and Flexible Solutions International Inc. a developer and manufacturer of biodegradable products, today announced that FSI has filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission on July 25, 2022 in connection with its proposed merger with Lygos. On April 18, 2022, Lygos and FSI announced a definitive merger agreement in an all-stock transaction ...

Read More

INDUSTRIAL IMPACT

PSYCHECEUTICAL COMPLETES ACQUISITION BY BLUE WATER VENTURES INTERNATIONAL

Blue Water Ventures International | January 20, 2022

news image

Psycheceutical, Inc. a biotechnology company dedicated to the development and commercialization of psychedelic medicines, announced the company has been fully acquired by Blue Water Ventures International, Inc. “We are thrilled that this deal has closed and that Psycheceutical is now a wholly-owned subsidiary of a publicly-listed company and has secured important near-term capital to pursue our growth plans. We will immediately begin the next steps of o...

Read More

CELL AND GENE THERAPY

CHILDHOOD TRAUMA AND GENETICS LINKED TO INCREASED OBESITY RISK

DRI | March 10, 2022

news image

New research from the Healthy Nevada Project® found associations between genetics, obesity, and childhood trauma, linking social health determinants, genetics, and disease. The study, which was published this week in Frontiers in Genetics, found that participants with specific genetic traits and who experience childhood traumas are more likely to suffer from adult obesity. In 2016, DRI and Renown Health launched the Healthy Nevada Project®, the nation’s first communi...

Read More

CELL AND GENE THERAPY

CSL PLASMA REIMAGINES DONOR EXPERIENCE WITH FIRST DONATIONS COMPLETED ON INNOVATIVE PLASMA COLLECTION TECHNOLOGY

CSL Plasma | August 08, 2022

news image

CSL Plasma, the plasma collection business of global biotherapeutics leader CSL Behring, began a new era in plasma donations, collecting its first plasma donations using leading-edge plasma collection technology that is expected to significantly reduce average collection time – by approximately one-third – and improve the donor experience. The Rika Plasma Donation System, only available at CSL Plasma and developed by Terumo Blood and Cell Technologies, is designe...

Read More
news image

INDUSTRIAL IMPACT

LYGOS AND FLEXIBLE SOLUTIONS INTERNATIONAL ANNOUNCE REGISTRATION STATEMENT ON FORM S-4 RELATED TO PROPOSED MERGER

Lygos Inc | July 26, 2022

Lygos Inc., a vertically integrated biotechnology provider of sustainable specialty ingredients, and Flexible Solutions International Inc. a developer and manufacturer of biodegradable products, today announced that FSI has filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission on July 25, 2022 in connection with its proposed merger with Lygos. On April 18, 2022, Lygos and FSI announced a definitive merger agreement in an all-stock transaction ...

Read More
news image

INDUSTRIAL IMPACT

PSYCHECEUTICAL COMPLETES ACQUISITION BY BLUE WATER VENTURES INTERNATIONAL

Blue Water Ventures International | January 20, 2022

Psycheceutical, Inc. a biotechnology company dedicated to the development and commercialization of psychedelic medicines, announced the company has been fully acquired by Blue Water Ventures International, Inc. “We are thrilled that this deal has closed and that Psycheceutical is now a wholly-owned subsidiary of a publicly-listed company and has secured important near-term capital to pursue our growth plans. We will immediately begin the next steps of o...

Read More
news image

CELL AND GENE THERAPY

CHILDHOOD TRAUMA AND GENETICS LINKED TO INCREASED OBESITY RISK

DRI | March 10, 2022

New research from the Healthy Nevada Project® found associations between genetics, obesity, and childhood trauma, linking social health determinants, genetics, and disease. The study, which was published this week in Frontiers in Genetics, found that participants with specific genetic traits and who experience childhood traumas are more likely to suffer from adult obesity. In 2016, DRI and Renown Health launched the Healthy Nevada Project®, the nation’s first communi...

Read More
news image

CELL AND GENE THERAPY

CSL PLASMA REIMAGINES DONOR EXPERIENCE WITH FIRST DONATIONS COMPLETED ON INNOVATIVE PLASMA COLLECTION TECHNOLOGY

CSL Plasma | August 08, 2022

CSL Plasma, the plasma collection business of global biotherapeutics leader CSL Behring, began a new era in plasma donations, collecting its first plasma donations using leading-edge plasma collection technology that is expected to significantly reduce average collection time – by approximately one-third – and improve the donor experience. The Rika Plasma Donation System, only available at CSL Plasma and developed by Terumo Blood and Cell Technologies, is designe...

Read More